咨询与建议

限定检索结果

文献类型

  • 2 篇 期刊文献
  • 2 篇 学位论文

馆藏范围

  • 4 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 4 篇 医学
    • 4 篇 临床医学

主题

  • 4 篇 acsm5
  • 2 篇 肺腺癌
  • 1 篇 early diagnosis
  • 1 篇 临床分析
  • 1 篇 免疫检查点
  • 1 篇 esophageal squam...
  • 1 篇 免疫组织化学
  • 1 篇 肝细胞肝癌
  • 1 篇 mir-4292
  • 1 篇 预后
  • 1 篇 genomic alterat...
  • 1 篇 生物标志物

机构

  • 1 篇 徐州医科大学
  • 1 篇 state key labora...
  • 1 篇 department of ga...
  • 1 篇 shenzhen peking ...
  • 1 篇 department of et...
  • 1 篇 research center ...
  • 1 篇 安徽医科大学
  • 1 篇 department of ga...
  • 1 篇 大连医科大学
  • 1 篇 department of ra...
  • 1 篇 department of pa...
  • 1 篇 novogene co.ltd ...
  • 1 篇 key laboratory o...
  • 1 篇 institute of can...
  • 1 篇 key laboratory o...

作者

  • 1 篇 xiaohan gao
  • 1 篇 jinting li
  • 1 篇 郭尧
  • 1 篇 xianfeng li
  • 1 篇 lianmei zhao
  • 1 篇 杨孝娟
  • 1 篇 dongmei lin
  • 1 篇 xuefeng liu
  • 1 篇 rui liu
  • 1 篇 wei sun
  • 1 篇 qimin zhan
  • 1 篇 qingjie min
  • 1 篇 jiawen fan
  • 1 篇 min zhang
  • 1 篇 jie chen
  • 1 篇 bin dong
  • 1 篇 yongping cui
  • 1 篇 汪永惠
  • 1 篇 陈全刚
  • 1 篇 刘昱含

语言

  • 3 篇 中文
  • 1 篇 英文
检索条件"主题词=ACSM5"
4 条 记 录,以下是1-10 订阅
排序:
acsm5在肝细胞肝癌中的表达及临床意义
ACSM5在肝细胞肝癌中的表达及临床意义
收藏 引用
作者: 杨孝娟 安徽医科大学
学位级别:硕士
目的:检测酰基辅酶A合成酶中链家族成员5(acyl-Co A synthetase medium-chain family member 5,acsm5)在肝细胞肝癌(hepatocellular carcinoma,HCC)及癌旁肝组织中的表达情况,探讨其与临床病理特征的关系及对肝癌预后的意义。方法:通过... 详细信息
来源: 同方学位论文库 同方学位论文库 评论
acsm5在肺腺癌中的临床意义以及与免疫浸润相关性的研究
ACSM5在肺腺癌中的临床意义以及与免疫浸润相关性的研究
收藏 引用
作者: 贺思静 大连医科大学
学位级别:硕士
目的探索acsm5(Acyl-coenzyme A synthetase Medium Chain Family Member 5,酰辅酶A合成酶中链家族5)在肺腺癌中的临床意义以及与免疫浸润的相关性。方法本研究通过分析TCGA(The Cancer Genome Atlas,癌症基因组图谱)数据库,探究acsm5... 详细信息
来源: 同方学位论文库 同方学位论文库 评论
基于数据挖掘分析acsm5在肺腺癌中的表达和临床意义
收藏 引用
中文科技期刊数据库(全文版)医药卫生 2023年 第4期 36-38页
作者: 汤恺成 刘昱含 汪永惠 郭尧 陈全刚 徐州医科大学生命科学学院 江苏徐州221000
探索中链酰基辅酶A合成酶5(Acyl-CoA Synthetase Medium Chain Family Member 5,acsm5)在肺腺癌中的表达和临床意义。方法 通过GEPIA2在线工具分析TCGA数据库中acsm5 mRNA在肺腺癌和正常肺组织中的表达情况,并进一步分析acsm5基因表达... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论
Genomic characterization and risk stratification of esophageal squamous dysplasia
收藏 引用
Medical Review 2024年 第3期4卷 244-256页
作者: Qingjie Min Min Zhang Dongmei Lin Weimin Zhang Xianfeng Li Lianmei Zhao Huajing Teng Tao He Wei Sun Jiawen Fan Xiying Yu Jie Chen Jinting Li Xiaohan Gao Bin Dong Rui Liu Xuefeng Liu Yongmei Song Yongping Cui Shih-Hsin Lu Ruiqiang Li Mingzhou Guo Yan Wang Qimin Zhan Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing) Laboratory of Molecular OncologyPeking University Cancer Hospital&InstituteBeijingChina Novogene Co.Ltd BeijingChina Department of Pathology Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing)Peking University Cancer Hospital&InstituteBeijingChina Department of Gastroenterology Daping HospitalArmy Medical University(Third Military Medical University)ChongqingChina Research Center The Fourth Hospital of Hebei Medical UniversityShijiazhuangHebeiChina Department of Radiation Oncology Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing)Peking University Cancer Hospital&InstituteBeijingChina Department of Gastroenterology&Hepatology Chinese PLA General HospitalBeijingChina Department of Etiology and Carcinogenesis and State Key Laboratory of Molecular Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina State Key Laboratory of Molecular Oncology Cancer Institute and Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing) Central LaboratoryPeking University Cancer Hospital&InstituteBeijingChina Institute of Cancer Stem Cell Dalian Medical UniversityDalianLiaoningChina Shenzhen Peking University-The Hong Kong University of Science and Technology(PKU-HKUST)Medical Center Peking University Shenzhen HospitalShenzhenGuangdongChina
Objectives:The majority of esophageal squamous dysplasia(ESD)patients progress slowly,while a subset of patients can undergo recurrence rapidly or progress to invasive cancer even after proper ***,the molecular mechan... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论